• Wion
  • /World
  • /Trump likely to pick John Hopkins surgeon, COVID mandate critic Martin Makary to lead FDA, say sources

Trump likely to pick John Hopkins surgeon, COVID mandate critic Martin Makary to lead FDA, say sources

Trump likely to pick John Hopkins surgeon, COVID mandate critic Martin Makary to lead FDA, say sources

US Food and Drug Administration

US President-elect Donald Trump will likely choose Johns Hopkins surgeon and writer Martin Makary to lead the Food and Drug Administration, two sources familiar with the matter told Reuters on Wednesday.

Makary raised concerns about a number of public health issues during the COVID-19 pandemic, touting the protection from natural immunity and opposing COVID vaccine mandates.

The FDA is the world's most influential drug regulator with a more than $7 billion budget. It is responsible for approving new treatments and assuring they are safe and effective before entering the biggest and most lucrative market. It has regulatory authority over human and veterinary drugs, biological medicines, medical devices and vaccines.

Add WION as a Preferred Source

The agency is also responsible for maintaining safety standards for the food supply, tobacco, cosmetics, and products that emit radiation.

Brian Hughes, a spokesperson for the Trump transition team, said he would not speculate on or get ahead of any announcement.

As FDA commissioner, Makary would report to the head of the Department of Health and Human Services.

To lead HHS, Trump has nominated Robert FKennedy Jr, an environmental activist who has spread misinformation about the safety of vaccines and one of several unconventional Trump picks for top administration jobs.

As a doctor, Makary was a co-developer of the Surgery Checklist, a routine for surgeons that improved patient outcomes and has been spread around the globe by the World Health Organization.

His most recent book, "Blind Spots", was published in September. In interviews promoting the book, he spoke against what he called "massive overtreatment" in the USthat he called "an epidemic of inappropriate care."

Watch |US: Trump, Musk Solidify Bond With Texas Trip

He has advocated for reexamining the use of hormone replacement treatment in menopausal women, reducing overuse of antibiotics and reforms to medical education.

Makary, who lives in Baltimore, has served as an adviser to Washington's conservative healthcare think tank Paragon Health Institute.

If confirmed by the Senate, he would succeed DrRobert Califf, a cardiologist and researcher who also held the role of FDA commissioner in the Obama administration.

In his second term, Califf revamped the agency's food operations and inspections processes and tried to combat misinformation.

Disclaimer: This story has been published from a news agency feed with minimal edits to adhere to WION's style guide. The headline may have been changed to better reflect the content of the story or to make it more suitable for WIONaudience.

About the Author

Mansi Arora

Ardent geopolitical news writer with a keen eye for global affairs. With passion for illuminating the complexities of global dynamics, Mansi explores her interests by delivering ne...Read More